Self-Testing Global Market Report 2024

The self-testing market size has grown strongly in recent years. It will grow from $13.9 billion in 2023 to $15.28 billion in 2024 at a compound annual growth rate (CAGR) of 9.9%. The growth observed during the historic period can be attributed to several factors, including educational reform movements aimed at enhancing access to education and knowledge dissemination, the advancements in scientific inquiry and the enlightenment period which fostered intellectual curiosity and exploration, the transformative effects of the industrial revolution which spurred innovation and technological progress, the evolution of healthcare and preventive medicine practices leading to improved public health outcomes, and the development of psychometric testing and personality assessment techniques facilitating better understanding of human behavior and cognition.

The self-testing market size is expected to see rapid growth in the next few years. It will grow to $22.67 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%. The anticipated growth in the forecast period can be attributed to several factors, including advancements in personalized medicine which tailor treatments to individual patients, the increasing prevalence of telehealth and remote monitoring technologies facilitating access to healthcare services, the growing demand for mental health support leading to expanded services and resources, and the proliferation of wearable health tech devices enabling continuous health monitoring. Key trends expected during this period include the adoption of point-of-care testing for rapid diagnostics, the implementation of blockchain-enabled data security to safeguard sensitive health information, the development of personalized wellness ecosystems integrating various health data sources, and the emergence of biohacking and quantified self movements focused on optimizing individual health and performance.

The self-testing market is poised for growth driven by the increasing prevalence of chronic diseases, which are characterized by long-lasting medical conditions. These conditions, influenced by demographic shifts, lifestyle choices, environmental factors, and healthcare advancements, necessitate active management and early detection. Self-testing plays a crucial role in chronic disease management by enabling individuals to monitor their health, adhere to treatment plans, and detect complications or changes in their condition. According to a report from the National Library of Medicine, the number of individuals with at least one chronic illness is projected to increase by 99.5% by 2050. This emphasis the rising demand for self-testing solutions.

Key players in the self-testing market are focused on innovation to enhance convenience, accessibility, and accuracy for users. For example, Pragmatech Healthcare Solutions introduced Cervicheck self-sampling kits in April 2023, offering women a convenient method to screen for the human papillomavirus (HPV), a major contributor to cervical cancer cases. This kit enables women to collect samples at home, addressing concerns about late detection due to reluctance to undergo testing at medical facilities. Featuring self-sampling and point-of-care detection, Cervicheck aims to empower women to detect cervical cancer early, thereby reducing mortality rates and the burden associated with late-stage cancer diagnosis.

In December 2021, in a strategic move to strengthen its digital at-home testing capabilities, Becton Dickinson Company acquired Scanwell Health Inc. This acquisition allows BD to leverage Scanwell's digital platform for developing at-home diagnostic tests for infectious diseases such as COVID-19, influenza A+B, group strep, and other chronic conditions. Scanwell Health Inc., known for its smartphone-enabled diagnostic self-testing kits, enhances BD's ability to provide innovative solutions for at-home testing, catering to the evolving needs of healthcare consumers.

Major companies operating in the self-testing market are Roche Diagnostics, Thermo Fisher Scientific Inc, Abbott Laboratories, Siemens Healthineers, Becton Dickinson and Company, Hologic Inc., PerkinElmer, BioMérieux, Sysmex Corporation, Bio-Rad Laboratories, Quidel Corporation, Cepheid, OraSure Technologies, Meridian Bioscience Inc., Ancestry.com DNA LLC, 23andMe Inc., MyHeritage Ltd., iHealth Labs Inc., Everly Health Inc., Helix OpCo LLC, BioIQ Inc., Veritas Intercontinental Inc., Pathway Genomics Corporation, Vitagene Inc., Orig3n Inc.

North America was the largest region in the self-testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the self-testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the self-testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Self-testing involves individuals conducting tests for specific medical conditions or characteristics using diagnostic tools or kits without the direct oversight of a healthcare professional. These tests enable individuals to monitor their health status, screen for particular conditions, or manage chronic diseases from the comfort of their homes. Self-testing offers benefits such as convenience, privacy, and empowerment for patients.

The primary types of products in self-testing include kits, devices, and strips. Kits typically comprise comprehensive packages containing all the essential materials and instructions required for individuals to collect and analyze their own samples. These kits can be utilized for various sample types, including blood, urine, stool, and others, and are accessible through different distribution channels, such as online and offline platforms. They serve a wide array of applications, including blood glucose testing, pregnancy and fertility testing, cancer screening, drug abuse testing, sexually transmitted disease or sexually transmitted infection testing, cholesterol testing, HIV testing, thyroid testing, among others.

The self-testing market research report is one of a series of new reports that provides self-testing market statistics, including self-testing industry global market size, regional shares, competitors with a self-testing market share, detailed self-testing market segments, market trends and opportunities, and any further data you may need to thrive in the self-testing industry. This self-testing market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The self-testing market consist of revenues earned by entities by providing services such as medical self-testing services, professional skills self-assessment services, medical stimulation services, and fitness and wellness self-testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The self-testing market also includes sales of medical self-testing products, health monitoring wearables, online symptom checkers, home diagnostic kits, personal health monitoring devices, and disease-specific testing kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.